BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30012297)

  • 1. Comparative Outcomes of Dupuytren Disease Treatment.
    Binhammer P
    Hand Clin; 2018 Aug; 34(3):377-386. PubMed ID: 30012297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Minimally Invasive Treatment of Dupuytren Disease.
    Hovius SER; Zhou C
    Hand Clin; 2018 Aug; 34(3):417-426. PubMed ID: 30012301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Recurrent Dupuytren Disease.
    Kaplan FTD; Crosby NE
    Hand Clin; 2018 Aug; 34(3):403-415. PubMed ID: 30012300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing It All Together: A Practical Approach to the Treatment of Dupuytren Disease.
    Haase SC; Chung KC
    Hand Clin; 2018 Aug; 34(3):427-436. PubMed ID: 30012302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Needle Aponeurotomy for Dupuytren Disease.
    Elzinga KE; Morhart MJ
    Hand Clin; 2018 Aug; 34(3):331-344. PubMed ID: 30012293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of Treatment for Dupuytren Disease.
    Eberlin KR; Mudgal CS
    Hand Clin; 2018 Aug; 34(3):387-394. PubMed ID: 30012298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of Dupuytren disease.
    Desai SS; Hentz VR
    J Hand Surg Am; 2011 May; 36(5):936-42. PubMed ID: 21527148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Direct Costs of Needle Aponeurotomy, Collagenase Injection, and Fasciectomy in the Treatment of Dupuytren Contracture.
    Leafblad ND; Wagner E; Wanderman NR; Anderson GR; Visscher SL; Maradit Kremers H; Larson DR; Rizzo M
    J Hand Surg Am; 2019 Nov; 44(11):919-927. PubMed ID: 31537401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
    Skov ST; Bisgaard T; Søndergaard P; Lange J
    J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
    Smeraglia F; Del Buono A; Maffulli N
    Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally Invasive Treatments of Dupuytren Disease: An Overview.
    Yeo JH; Kim JY
    J Hand Surg Asian Pac Vol; 2021 Jun; 26(2):131-141. PubMed ID: 33928844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupuytren Contractures: An Update of Recent Literature.
    Boe C; Blazar P; Iannuzzi N
    J Hand Surg Am; 2021 Oct; 46(10):896-906. PubMed ID: 34452797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.
    Strömberg J; Ibsen Sörensen A; Fridén J
    J Bone Joint Surg Am; 2018 Jul; 100(13):1079-1086. PubMed ID: 29975270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.
    Lipman MD; Carstensen SE; Deal DN
    Hand (N Y); 2017 Jan; 12(1):13-20. PubMed ID: 28082837
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
    Sanjuan Cerveró R; Franco Ferrando N; Poquet Jornet J
    BMC Musculoskelet Disord; 2013 Oct; 14():293. PubMed ID: 24125161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment options for Dupuytren's surgery: collagenase and percutaneous aponeurotomy.
    Srinivasan RC; Shah AS; Jebson PJ
    J Hand Surg Am; 2010 Aug; 35(8):1362-4. PubMed ID: 20434276
    [No Abstract]   [Full Text] [Related]  

  • 19. Dupuytren Disease Management Trends: A Survey of Hand Surgeons.
    Paynter JA; Tobin V; Rozen WM; Hunter-Smith DJ
    J Hand Surg Asian Pac Vol; 2020 Dec; 25(4):453-461. PubMed ID: 33115367
    [No Abstract]   [Full Text] [Related]  

  • 20. Collagenase Treatment Versus Needle Fasciotomy for Single-Digit Dupuytren Contractures: A Meta-Analysis of Randomized Controlled Trials.
    Zhang D; Earp BE; Blazar P
    J Hand Surg Am; 2023 Dec; 48(12):1200-1209. PubMed ID: 37725027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.